Quantcast

Latest Mayo Clinic Stories

2013-02-28 10:57:45

Researchers have identified a possible treatment window of several years for plaques in the brain that are thought to cause memory loss in diseases such as Alzheimer's. The Mayo Clinic study is published in the Feb. 27 online issue of Neurology, the medical journal of the American Academy of Neurology. "Our study suggests that plaques in the brain that are linked to a decline in memory and thinking abilities, called beta amyloid, take about 15 years to build up and then plateau," says lead...

2013-02-19 15:11:12

Therapy to ease stress, fatigue and other quality of life issues significantly improves patients' sense of well-being during cancer treatment, new Mayo Clinic research shows. Patients who kept to their standard routines showed a decline in quality of life measures, the study found. The findings are published this month in Cancer. Mayo cancer care specialists created a six-session program to address cognitive, physical, emotional, social and spiritual well-being. Each session includes...

2013-02-19 14:31:14

Current national guidelines provide benchmarks regarding the number of polyps physicians should detect, on average, during a colonoscopy. Recent studies at Mayo Clinic's campus in Florida suggest these benchmarks may be too low. Their study, in the online issue of Gastrointestinal Endoscopy, found that use of high-definition imaging tools in 2,400 individuals undergoing a screening colonoscopy at the clinic led to an adenoma detection rate (ADR) of 25 percent in women and 41 percent in...

2013-02-12 20:29:59

Researchers at Mayo Clinic have discovered an abnormal protein that accumulates in the brains of many patients affected with two common neurodegenerative disorders – amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, and frontotemporal dementia. They say their findings have uncovered a potentially new therapeutic target and biomarker that would allow clinicians to confirm diagnosis of the diseases. The study is published online today in the journal Neuron. The...

2013-01-04 11:02:11

Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy. The findings are published in the Jan. 3 online issue of PLOS ONE. The researchers decoded a molecular pathway that is switched "on" at all times, promoting accelerated growth of pancreatic tumors, and that...

2012-12-18 14:19:05

Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer. Their study, published in the Dec. 18 online edition of Molecular Cancer Research, is the first to link the enzyme PRSS3 to prostate cancer. "This molecule is a protease, which means it digests other molecules. Our data suggests PRSS3...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related